Magnetic resonance imaging of endometrial carcinoma

Journal of Computer Assisted Tomography

Volumn 33, Issue 4, 2009, Pages 601-608

  Peungjesada, Silanath ^a   Bhosale, Priya R ^b   Balachandran, Aparna ^a   Iyer, Revathy B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diagnosis; Endometrial; MRI; Staging

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; SURGERY; TUMORS; ULTRASONIC APPLICATIONS;

CROSS-SECTIONAL IMAGING; ENDOMETRIAL; ENDOMETRIAL CANCER; ENDOMETRIAL CARCINOMAS; FEMALE PELVIC; HIGH INCIDENCE; INTERNATIONAL FEDERATION; STAGING; SURGICAL PLANNING; SURGICAL SYSTEMS;

MAGNETIC RESONANCE IMAGING;

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COILED BODY; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; ENDOMETRIUM CARCINOMA; HUMAN; INVASIVE PROCEDURE; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROCTITIS; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TRANSVAGINAL ECHOGRAPHY; TREATMENT PLANNING; UTERUS;

EID: 68949144861     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31818d4279     Document Type: Review

References (46)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71Y96.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74Y108.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10Y30.
4. Daniels RV, McCuskey C. Abnormal vaginal bleeding in the nonpregnant patient. Emerg Med Clin North Am. 2003;21:751Y772.
5. Chaudhry S, Reinhold C, Guermazi A, et al. Benign and malignant diseases of the endometrium. Top Magn Reson Imaging. 2003;14: 339Y357.
6. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2008;111:436Y447.
7. Ascher SM, Reinhold C. Imaging of cancer of the endometrium. Radiol Clin North Am. 2002;40:563Y576.
8. Ascher SM, Takahama J, Jha RC. Staging of gynecologic malignancies. Top Magn Reson Imaging. 2001;12:105Y129.
9. Frei KA, Kinkel K. Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging. 2001;13:850Y855.
10. Manfredi R, Gui B, Maresca G, et al. Endometrial cancer: magnetic resonance imaging. Abdom Imaging. 2005;30:626Y636.
11. Nordstrom B, Strang P, Lindgren A, et al. Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol. 1996;15:191Y201.
12. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol. 1989;96:889Y892.
13. Reinhold C GB, Ascher SM. Uterus, Cervix. New York: Wiley-Liss; 1997.
14. Creasman W. Malignant Tumors of the Uterine Corpus. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003.
15. Barakat RRGP, Zaino SP. Corpus Epithelial Tumors. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000.
16. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29Y33.
17. Kirby TO, Leath CA 3rd, Kilgore LC. Surgical staging in endometrial cancer. Oncology (Huntingt). 2006;20:45Y50; discussion 50, 53Y54, 63.
18. Homesley HD, Boike G, Spiegel GW. Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a Gynecologic Oncology Group study. Int J Gynecol Cancer. 2004;14:341Y347.
19. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 1987;60:2035Y2041.
20. Rubin SC, Hoskins WJ, Saigo PE, et al. Management of endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1992;45:294Y298.
21. Marti-Bonmati L, Graells M, Ronchera-Oms CL. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging. 1996;21: 309Y313.
22. Dosda R, Marti-Bonmati L, Ronchera-Oms CL, et al. Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol. 2003;13:294Y298.
23. Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004;231:372Y378.
24. Nasi F, Fiocchi F, Pecchi A, et al. MRI evaluation of myometrial invasion by endometrial carcinoma. Comparison between fast-spin-echo T2w and coronal-FMPSPGR Gadolinium-Dota-enhanced sequences. Radiol Med (Torino). 2005;110:199Y210.
25. Kinkel K. Pitfalls in staging uterine neoplasm with imaging: a review. Abdom Imaging. 2006;31:164Y173.
26. Rockall AG, Meroni R, Sohaib SA, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer. 2007;17:188Y196.
27. Utsunomiya D, Notsute S, Hayashida Y, et al. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images. AJR Am J Roentgenol. 2004;182:399Y404.
28. Olson MC, Posniak HV, Tempany CM, et al. MR imaging of the female pelvic region. Radiographics. 1992;12:445Y465.
29. Kubic-Huch RA, Reinhold C, Semelka RC, Michel SCA, Pedro MS. Uterus and Cervix. Hoboken, NJ: Wiley-Liss; 2006.
30. Saez F, Urresola A, Larena JA, et al. Endometrial carcinoma: assessment of myometrial invasion with plain and gadolinium-enhanced MR imaging. J Magn Reson Imaging. 2000;12:460Y466.
31. Nakao Y, Yokoyama M, Hara K, et al. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol. 2006;102:343Y347.
32. Murakami T, Kurachi H, Nakamura H, et al. Cervical invasion of endometrial carcinoma-evaluation by parasagittal MR imaging. Acta Radiol. 1995;36:248Y253.
33. Shibutani O, Joja I, Shiraiwa M, et al. Endometrial carcinoma: efficacy of thin-section oblique axial MR images for evaluating cervical invasion. Abdom Imaging. 1999;24:520Y526.
34. Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol. 2005;23: 2813Y2821.
35. Vassallo P, Matei C, Heston WD, et al. AMI-227Yenhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology. 1994;193:501Y506.
36. Jeong YY, Kang HK, Chung TW, et al. Uterine cervical carcinoma after therapy: CT and MR imaging findings. Radiographics. 2003;23:969Y981; discussion 981.
37. Rosse C G-RP, eds. Hollinshead's Textbook of Anatomy. Philadelphia, Pa: Lippincott Raven Publishers; 1997.
38. Thibodeau GA PK. Female Reproductive System. St. Louis, Mo: Mosby; 1999.
39. Barakat RR, Goldman NA, Patel DA, et al. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol. 1999;75:99Y102.
40. Viswanathan AN, Cormack R, Holloway CL, et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006;66:91Y99.
41. Sugimura K, Okizuka H. Postsurgical pelvis: treatment follow-up. Radiol Clin North Am. 2002;40:659Y680, viii.
42. Sohaib SA, Houghton SL, Meroni R, et al. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol. 2007;62:28Y34; discussion 35Y36.
43. Goldberg H, Miller RC, Abdah-Bortnyak R, et al. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol. 2008;108:298Y305.
44. Maingon P, Horiot JC, Fraisse J, et al. Preoperative radiotherapy in stage I/II endometrial adenocarcinoma. Radiother Oncol. 1996;39:201Y208.
45. Abu-Rustum NR, Iasonos A, Zhou Q, et al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol. 2008;198:457.e1Ye5; discussion 457 e5Ye6.
46. Hogberg T. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol (R Coll Radiol). 2008.